{"disease":{"id":"mps-i","name":"mps i"},"drugs":{"marketed":[{"drug_id":"elosulfase-alfa","indication_name":"Mucopolysaccharidosis, MPS-IV-A","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rhgalns","generic_name":"ELOSULFASE ALFA","company_name":"BioMarin","drug_phase":"marketed","molecular_target":"N-acetylgalactosamine-6-sulfatase","drug_class":"Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]","quality_score":55,"revenue":"500","mechanism":"VIMIZIM provides exogenous N-acetylgalactosamine-6-sulfatase to increase the catabolism of GAGs KS and C6S in lysosomes."},{"drug_id":"laronidase","indication_name":"Mucopolysaccharidosis, MPS-I","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldurazyme","generic_name":"LARONIDASE","company_name":"BioMarin","drug_phase":"marketed","molecular_target":"","drug_class":"Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]","quality_score":50,"revenue":"300","mechanism":"Aldurazyme breaks down abnormal sugar molecules in the body to treat Mucopolysaccharidosis I."},{"drug_id":"copper","indication_name":"nighttime cramps in thighs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in calves","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in feet","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in toes","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"elaprase","indication_name":"Mucopolysaccharidosis, MPS-II","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Elaprase","company_name":"Shire","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"aldurazyme","indication_name":"Mucopolysaccharidosis, MPS-I","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aldurazyme","company_name":"Genzyme, a Sanofi Company","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"vestronidase-alfa","indication_name":"Mucopolysaccharidosis, MPS-VII","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepsevii","generic_name":"VESTRONIDASE ALFA","company_name":"Ultragenyx Pharm Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Lysosomal beta Glucuronidase [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepsevii works by replacing the deficient enzyme beta-glucuronidase in patients with MPS-VII."},{"drug_id":"idursulfase","indication_name":"Mucopolysaccharidosis, MPS-II","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Elaprase","generic_name":"IDURSULFASE","company_name":"Takeda","drug_phase":"marketed","molecular_target":"","drug_class":"Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]","quality_score":50,"revenue":null,"mechanism":"Elaprase works by replacing the deficient enzyme iduronate-2-sulfatase in the body."},{"drug_id":"vestronidase-alfa-vjbk","indication_name":"Mucopolysaccharidosis, MPS-VII","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MEPSEVII","generic_name":"VESTRONIDASE ALFA-VJBK","company_name":"ULTRAGENYX PHARM INC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"mepsevii","indication_name":"Mucopolysaccharidosis, MPS-VII","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mepsevii","company_name":"Ultragenyx Pharmaceutical Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cesium","indication_name":"Muscle cramps relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurotox","generic_name":"CESIUM","company_name":"BioActive Nutritional, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in legs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"chlorthalidone","indication_name":"Cardiac effects of mineralocorticoid receptor antagonism after preeclampsia","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":14,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT05810545","title":"Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity","phase":"","overall_status":"COMPLETED","enrollment_count":256659,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03330301","title":"D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life","phase":"","overall_status":"COMPLETED","enrollment_count":222776,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT02468310","title":"Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana","phase":"NA","overall_status":"COMPLETED","enrollment_count":65831,"lead_sponsor_name":"Hannah Brown Amoakoh","has_results":false},{"nct_id":"NCT06383858","title":"The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"The Third Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT03941886","title":"Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)","phase":"NA","overall_status":"COMPLETED","enrollment_count":42454,"lead_sponsor_name":"Chiu Yee Liona Poon","has_results":false},{"nct_id":"NCT03151070","title":"Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design","phase":"","overall_status":"COMPLETED","enrollment_count":32000,"lead_sponsor_name":"Hospital San Juan de Dios Guatemala","has_results":false},{"nct_id":"NCT06653374","title":"Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns","phase":"","overall_status":"COMPLETED","enrollment_count":26000,"lead_sponsor_name":"HOSPITAL GINECO OBSTETRICO ISIDRO AYORA","has_results":false},{"nct_id":"NCT05131282","title":"Maternal Serum Markers Predicting Preeclampsia At Early Gestations","phase":"","overall_status":"COMPLETED","enrollment_count":18000,"lead_sponsor_name":"HBI Solutions Inc.","has_results":false},{"nct_id":"NCT03831490","title":"Study for Improving Maternal, Pregnancy and Child Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":13000,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT03665623","title":"Prediction of Preeclampsia by Comprehensive Markers.","phase":"","overall_status":"COMPLETED","enrollment_count":11741,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06468202","title":"Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":10742,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT05445544","title":"A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT06074601","title":"MIRACLE of LIFE Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Mirvie","has_results":false},{"nct_id":"NCT04990141","title":"Molecular Screening Method for Preeclampsia (PREMOM)","phase":"","overall_status":"COMPLETED","enrollment_count":9586,"lead_sponsor_name":"iPremom","has_results":false},{"nct_id":"NCT04766866","title":"sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.","phase":"NA","overall_status":"RECRUITING","enrollment_count":9132,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT06339606","title":"Pregnancy Repository","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT06643741","title":"Non-Invasive Preeclampsia Screening and Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":6550,"lead_sponsor_name":"Sequenom, Inc.","has_results":false},{"nct_id":"NCT03780179","title":"MMR at 6 Months Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6540,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT01681992","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4538,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05752955","title":"SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth","phase":"NA","overall_status":"COMPLETED","enrollment_count":3446,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT00560755","title":"Safety Study of ProQuad® rHA in Infants (V221-037)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3388,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01648842","title":"Vitamin D and Preeclampsia","phase":"","overall_status":"COMPLETED","enrollment_count":3173,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03334149","title":"Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":3042,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06115122","title":"PEPPI Study: Identification of Women at Risk for Placental Dysfunction","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Oulu University Hospital","has_results":false},{"nct_id":"NCT03978429","title":"An mHealth Strategy to Reduce Pre-Eclampsia and Infant Death in Tanzania","phase":"NA","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Dr. Karen Yeates","has_results":false},{"nct_id":"NCT05580523","title":"Aspirin Versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06323187","title":"Optimization of Cervical Collections in Pregnancy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2600,"lead_sponsor_name":"Dr. Sascha Drewlo","has_results":false},{"nct_id":"NCT07187596","title":"Mortality Outcome of Controlled Hypertension","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2547,"lead_sponsor_name":"DejthidaNathaphong","has_results":false},{"nct_id":"NCT03231657","title":"Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":2536,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT02881073","title":"Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia","phase":"NA","overall_status":"COMPLETED","enrollment_count":2313,"lead_sponsor_name":"Irish Centre for Fetal and Neonatal Translational Research","has_results":false},{"nct_id":"NCT03342014","title":"First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography","phase":"NA","overall_status":"COMPLETED","enrollment_count":2159,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT04021680","title":"Clinical Effectiveness of First Trimester Pre-eclampsia Screening Program.","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT07015203","title":"The Combined First Trimester Screening","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Institute of Health Information and Statistics of the Czech Republic","has_results":false},{"nct_id":"NCT06921629","title":"Menstrual Complaints in Adolescents and Adults","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT06414655","title":"Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT07510568","title":"Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregnancy, and Other Adverse Maternal and Foetal Outcomes","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":1980,"lead_sponsor_name":"St Mary's Hospital, Lacor","has_results":false},{"nct_id":"NCT00326183","title":"Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06111079","title":"Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"FANG HE","has_results":false},{"nct_id":"NCT02184572","title":"Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1742,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00566527","title":"Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1620,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04424693","title":"Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":1600,"lead_sponsor_name":"Institute of Arthritis Research","has_results":false},{"nct_id":"NCT06842875","title":"Rhode Island - Statewide Postpartum Hypertension Remote Surveillance","phase":"NA","overall_status":"RECRUITING","enrollment_count":1536,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false},{"nct_id":"NCT05237011","title":"Peripartum Anesthetic Management of Patients With Preeclampsia","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Shaare Zedek Medical Center","has_results":false},{"nct_id":"NCT03487185","title":"Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy","phase":"NA","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"The George Washington University Biostatistics Center","has_results":false},{"nct_id":"NCT04631627","title":"Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03510286","title":"Validation of a PrCr Dipstick Diagnostic Test in Ghana","phase":"","overall_status":"COMPLETED","enrollment_count":1483,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT07106294","title":"Hyperspectral Imaging for Prediction of Preeclampsia","phase":"","overall_status":"RECRUITING","enrollment_count":1430,"lead_sponsor_name":"Heidelberg University","has_results":false},{"nct_id":"NCT04075708","title":"Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy","phase":"","overall_status":"COMPLETED","enrollment_count":1427,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT01536405","title":"Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1412,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}